Laura Wormser
Laura Wormser is an expert in Gastroenterology at Universitätsklinikum Erlangen (Germany). Laura Wormser has authored 13 publications, the most recent in 2026. SLR score: 44 (community average: 125). How the SLR is computed.
LeadR Profile
Gastroenterology
Subspecialties:
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2026 - 2026
Number : 13
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Pancreatic polypeptide interacts with neuropeptide Y4 receptor to promote hepatocellular carcinoma progression. PMID 42615099 — cells, carcinoma, hepatocellular, pathology, sorafenib, pancreatic polypeptide, liver neoplasms, neuropeptides | J Pathol | 2026 | 0 |
| The liver talks back: NPY orchestrates attraction of cancer cells and CHK2-dependent clonogenicity in the metastatic niche. PMID 41252148 — cells, hepatocytes, neoplasms, liver, neoplasm metastasis, therapeutics, rna interference, lipid nanoparticles | Proc Natl Acad Sci U S A | 2025 | 0 |
| Identification of novel targets of miR-622 in hepatocellular carcinoma reveals common regulation of cooperating genes and outlines the oncogenic role of zinc finger CCHC-type containing 11. PMID 33901943 — cells, genes, carcinoma, hepatocellular, micrornas, neoplasms, liver, liver neoplasms, drug resistance | Neoplasia | 2021 | 8 |
| Combined De-Repression of Chemoresistance Associated Mitogen-Activated Protein Kinase 14 and Activating Transcription Factor 2 by Loss of microRNA-622 in Hepatocellular Carcinoma. PMID 33803354 — cells, genes, mitogens, carcinoma, hepatocellular, protein kinases, activating transcription factor 2, micrornas, transcription factors, mitogen-activated protein kinases, sorafenib, repression, psychology, liver neoplasms, mitogen-activated protein kinase 14 | Cancers (Basel) | 2021 | 6 |
| Molecular crosstalk between Y5 receptor and neuropeptide Y drives liver cancer. PMID 31999643 — hepatocytes, neoplasms, liver, liver neoplasms, neuropeptides, neuropeptide y | J Clin Invest | 2020 | 34 |
LeadR Networks
Main global connection map